clinical trial · NCT07748702
Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy Volunteers
HypertensionCKD-339D311, D107
brief summary
This study is a randomized, open-label, single dose, crossover study to evaluate the pharmacokinetics and safety of CKD-339 in healthy volunteers.
started
Sep 19, 2026
primary completion
Oct 7, 2026
completion
Oct 29, 2026
last updated
Nov 13, 2026
detailed description
To 76 healthy subjects, following treatments, are administered dosing in each period and wash-out period is 14 days.
Pharmacokinetic blood samples are collected up to 72hrs. The pharmacokinetic characteristics and safety are assessed.
official title
An Open Label, Randomized, Single Dose, Crossover, Phase I Study to Evaluate the Pharmacokinetics and the Safety of D311 and D107 Compared to CKD-339 in Healthy Adult Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol